Amalgamated Financial’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Amalgamated Financial’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$16K	Buy	+1,366	New	+$16.3K	﹤0.01%	2809

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amalgamated Financial's OYST Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022: 1,366 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #2809 among its holdings.

72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

Amalgamated Financial held 1,366 shares of Oyster Point Pharma, Inc. Common Stock worth $16K as of Q1 2022.
Oyster Point Pharma, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Oyster Point Pharma, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2809 holding.
72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.